Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications

Similar documents
Outbreak Control Policy

Animals and Pets in Healthcare Facilities Policy

Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications

Aseptic Technique Policy

Provision of Wigs Policy

Respiratory Syncytial Virus (RSV) Policy for the Management of

Protective Isolation Policy

Glycopeptide/Vancomycin Resistant Enterococci (GRE/VRE) Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

GCP Training for Research Staff. Document Number: 005

Safe Bathing Policy V1.3

Version: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

Document Title: Training Records. Document Number: SOP 004

MOVING TO ALTERNATIVE PREMISES (SERVICE/TEAM/STAFF) POLICY

OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Central Alerting System (CAS) Policy

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

Document Title: Recruiting Process. Document Number: 011

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

WARD CLOSURE POLICY V

Policy on Governance Arrangements Relating to Medicines V2.0

Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation

Impact Assessment Policy. Document author Assured by Review cycle. 1. Introduction Policy Statement Purpose or Aim Scope...

Moving and Handling Policy

INFECTION CONTROL SURVEILLANCE POLICY

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

Job Title 22 February 2013

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

SABP/INFORMATIONSECURITY- SUMMARY CARE RECORD ACCESS/0003

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Decontamination of Healthcare Equipment following Patient Use and Prior to Service or Repair

Diagnostic Testing Procedures in Neurophysiology V1.0

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines

CCG CO16 Safeguarding Vulnerable Adults Policy

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Tissue Viability Referral Pathway. April 2017

Health and Safety Policy

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy

Executive Director of Nursing and Chief Operating Officer

Document Title: File Notes. Document Number: 024

Diagnostic Testing Procedures in Urodynamics V3.0

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

Hospital Outbreak Management Policy

Document Title: Research Database Application (ReDA) Document Number: 043

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care

Document Title: Research Database Application (ReDA) Document Number: 043

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

Access to Health Records Procedure

Consulted With Individual/Body Date. Last reviewed Mags Shaughnessy Director of Operations 16 August Operations

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy

This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services

Document Title: Version Control of Study Documents. Document Number: 023

Loading Dose Worksheet for Oral Amiodarone

Health and Safety Strategy

Infection Prevention and Control: Audit Policy

Prof. Paula Whitty Director of Research, Innovation and Clinical Effectiveness. Author(s) (name and designation) Date ratified January 2015

Manual Handling Policy

CO33: Policy for commissioning of a care provision within the continuing healthcare pathway

Document Title: Document Number:

Diagnostic Testing Procedures for Ophthalmic Science

Document Details Title

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018

Non Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact

Pan Dorset Procedure for the Management of the Closure of a Care Home Supporting people in Dorset to lead healthier lives

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Trust Quality Impact Assessment (QIA) Policy

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance

Mental Health Social Work: Community Support. Summary

NHS Continuing Healthcare Choice Policy Supporting people in Dorset to lead healthier lives

School Vision Screening Policy V2.0

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy

Dignity and Respect Charter for patients. Version 6.0

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY

Sarah Murray CF Nurse Specialist

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0

Version Number Date Issued Review Date V1: 28/02/ /08/2014

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Agenda item 3.3 Appendix 4 MANDATORY TRAINING POLICY

SAFEGUARDING CHILDEN POLICY. Policy Reference: Version: 1 Status: Approved

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY

Medical Devices Management Policy

your hospitals, your health, our priority CATHETERISATION Urethral/ supra-pubic POLICY NAME: VERSION NUMBER : 1 PROFESSIONAL ADVISORY BOARD (PAB)

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

MANAGEMENT OF ASBESTOS

Type: Policy Register No: Status: Public. Production and Use of Ice SOP

Open Door Policy (replacing policy no. 030/Clinical)

Central Alert System (CAS) RISK MANAGEMENT POLICY /PROCEDURE: CENTRAL ALERT SYSTEM (CAS)

Transcription:

Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Lead Nurse/Director for Infection Prevention and Control Judy Potter, Lead Nurse/ Director for Infection Prevention and Control Specialist Services / Infection Prevention & Control x2355 Date of original document 17/02/2014 Impact Assessment performed Ratifying body and date ratified Review date (and frequency of further reviews) Yes/ No Infection Control and Decontamination Assurance Group: 17 th May 2017 October 2021 (5 yearly) Expiry date April 2022 Date document becomes live 30 May 2017 Please specify standard/criterion numbers and tick other boxes as appropriate Monitoring Information Patient Experience Assurance Framework Monitor/Finance/Performance CQC Fundamental Standards - Regulation: 8 Strategic Directions Key Milestones Maintain Operational Service Delivery Integrated Community Pathways Develop Acute services Infection Control Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications Controlled document This document has been created following the Royal Devon and Exeter NHS Foundation Trust Development, Ratification & Management of Procedural Documents Policy. It should not be altered in any way without the express permission of the author or their representative. Review Date: October 2021 Page 1 of 12

Full History Version Date Author (Title not name) 1.0 17/02/2014 Lead Nurse/Director of Infection Prevention & Control 2.0 28/03/2017 Senior Nurse Infection Prevention & Control Status: Final Reason New policy - A policy such as this is recommended in the The Health and Social Care Act 2008 Code of Practice on the prevention and control of infections and related guidance Routine revision harmonised with community services requirements Associated Trust Policies/ Procedural documents: Cleaning Policy Decontamination Policy and Procedures Infection Prevention & Control Policy Waste Management Policy Water Safety Policy Key Words Estates, environment, buildings, legionella, ventilation, facilities In consultation with and date: Estates: 28 th March 2017 Policy Expert Panel (PEP): 5 th April 2017 Head of Chaplaincy and Volunteer Services/Patient Equality Lead: 19 th April 2017 Full membership of the Infection Control and Decontamination Assurance Group which includes representation from the executive team, divisional management teams (including community services), nursing and medical staff, therapists, facilities, operations support, estates and Public Health England s Devon/Cornwall and Somerset Local Team: 17 th May 2017. Review Date (Within 5 years) October 2021 Contact for Review: Lead Nurse/Director of Infection Prevention & Control Executive Lead Signature: Medical Director Review Date: October 2021 Page 2 of 12

CONTENTS 1. INTRODUCTION... 4 2. PURPOSE... 4 3. DEFINITIONS... 4 4. DUTIES & RESPONSIBILITIES... 4 5. STAGES AT WHICH INPUT FROM THE IPCT SHOULD BE SOUGHT... 6 6. ARCHIVING ARRANGEMENTS... 8 7. PROCESS FOR MONITORING COMPLIANCE WITH AND EFFECTIVENESS OF THE POLICY... 8 8. REFERENCES... 8 APPENDIX 1: COMMUNICATION PLAN... 10 APPENDIX 2: EQUALITY IMPACT ASSESSMENT TOOL... 11 Review Date: October 2021 Page 3 of 12

1. INTRODUCTION 1.1 High standards of environmental hygiene and clinical practice in healthcare facilities have been identified as being important in minimising the risk of the transmission of infection. Health Building Note (HBN) 00:09 identifies that the design, planning, construction, refurbishment and on-going maintenance of the healthcare facility also have an important role to play in the prevention and control of infection. The physical environment has to assist, not hinder, good practice. 1.2 It is important that infection prevention and control (IPC) is designed-in at the planning and design stages of a new-build or refurbishment project and that input continues up to the final build stage. Designed-in IPC means that designers, architects, engineers, facilities managers and planners work in collaborative partnership with IPC teams to deliver facilities in which IPC needs have been planned for, anticipated and met (HBN 00:09). 1.2 Failure to comply with this policy could result in disciplinary action. 2. PURPOSE 2.1 This policy highlights IPC issues and risks that need to be addressed at each particular stage to achieve designed-in infection control. The aim is to prompt those with overall responsibility for managing capital schemes to include IPC advice at the right time in order to prevent costly mistakes. 3. DEFINITIONS 3.1 New build construction of new buildings 3.2 Refurbishment renovating, re-equipping, or restoring existing buildings 4. DUTIES & RESPONSIBILITIES OF STAFF 4.1 The Chief Executive is responsible for: ensuring there are systems in place to provide healthcare premises that are suitable for purpose and are kept clean and maintained in good physical repair and condition. 4.2 The Director of Finance is responsible for: the provision and management of sufficient financial resources to enable those involved in new builds and refurbishment to effectively discharge their legal responsibilities and duty of care. 4.3 The Director for Infection Prevention and Control (DIPC) is responsible for: Formal sign off of plans Ensuring that there is an infection control specialist or microbiologist involved as a member of the project team Review Date: October 2021 Page 4 of 12

4.4 Project Managers/Estates Officers are responsible for: ensuring that all infection prevention and control issues, that relate to each building and engineering project, are discussed with a member of the Infection Prevention & Control Team (IPCT) at the earliest possible stage. consulting the IPCT if there are any changes to the plans that may have an impact on infection prevention and control. following the guidance in HBN 00-09 in relation to designing, planning, constructing and commissioning a new or refurbishment building scheme as far as is reasonably practicable. liaison with the estates representatives of community site owners (e.g. NHS Property Services, PFI, DPT, etc.) to ensure the necessary adherence to engineering and building HTM regulations are maintained (to include assurance of water safety and ventilation maintenance and periodic testing). in the event of such assurance checks failing to meet national standards the infection control team should be notified. 4.5 The Infection Prevention and Control Team (IPCT) are responsible for: providing guidance and support to building and engineering project teams. carrying out relevant risk assessments and method statements [for example, to assess the risk of infection during building work to immuno-compromised patients from airborne spores of Aspergillus (environmental fungi)]. attending project meetings and visits in order to ensure consultation and sign off takes place in a timely manner, and so as not to unnecessarily delay any particular scheme. attending the clinical area for a pre-handover inspection of the scheme and for final sign off. in the event of estates assurance checks failing to meet national standards the infection control team should risk assess the impact to staff and service users and take necessary action to maintain their safety 4.6 Departmental Manager/Matron is responsible for: outlining the operational policy detailing the uses and requirements of the facility at the project inception. ensuring that infection control measures are implemented and adhered to throughout. liaison with hotel services regarding cleaning during and on completion of projects. ensuring any suspension of clinical activity in an area is notified to the facilities and estates teams to allow water safety to be maintained through additional water flushing or other measures. Review Date: October 2021 Page 5 of 12

5. STAGES AT WHICH INPUT FROM THE IPCT SHOULD BE SOUGHT 5.1 HBN 09:09 provides detailed guidance on the nature of the input at each stage of the planning process and this should be referred to at each stage for clarity. The stages at which input is required are as follows: Preparation of a business case to support the viability of the project. Project funding Concept/feasibility study. Design stage. Contract. Project monitoring/construction. Pre-handover inspections ( snagging ). Commissioning the facility. Post-project evaluation. 5.2 In addition to new build and refurbishments, areas will from time to time be subject to temporary or long-term variation in use. Estates teams must be notified and IPCT advice should be sought for any areas under temporary closure/ decommissioning to ensure any risks are identified and mitigated e.g. water safety. 5.3 Figure 1 provides examples about the type of issues to be considered at each stage. Review Date: October 2021 Page 6 of 12

FIGURE 1 - THE PLANNING PROCESS Ratified by: Infection Control & Decontamination Assurance Group: Review Date: Page 7 of 12

6. ARCHIVING ARRANGEMENTS The original of this policy, will remain with the author, Lead Nurse, Infection Prevention & Control. An electronic copy will be maintained on the Trust Intranet, P Policies (Trust-wide) I Infection Control in the Built Environment. Archived electronic copies will be stored on the Trust's archived policies shared drive, and will be held indefinitely. A paper copy (where one exists) will be retained for 10 years. 7. PROCESS FOR MONITORING COMPLIANCE WITH AND EFFECTIVENESS OF THE POLICY 7.1 In order to monitor compliance with this policy, the auditable standards will be monitored as follows: No Minimum Requirements Evidenced by 1. There is input from the infection prevention and control team at each of the stages identified in this policy Project meeting notes 2. The DIPC signs off the final plans Project meeting notes 3. Where deviation from infection control advice is necessary, the rationale is documented and the risk is assessed. Risk assessment 7.2 Frequency In each financial year, the Head of Estates will audit a small selection of project records to ensure that this policy has been adhered to and a formal report will be written and presented at the Infection Control & Decontamination Assurance Group. 7.3 Undertaken by Head of Estates 7.4 Dissemination of Results 7.5 Recommendations/ Action Plans Implementation of the recommendations and action plan will be monitored by the Infection Control & Decontamination Assurance Group, which meets 4 times per year. 7.6 Any barriers to implementation will be risk-assessed and added to the risk register. 7.7 Any changes in practice needed will be highlighted to Trust staff via the Governance Managers cascade system. 8. REFERENCES Department of Health (2011) The Health and Social Care Act (2008): Code of Practice for the Prevention of Infections and Related Guidance. Available at https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/21622 7/dh_123923.pdf Accessed 17/2/14 Review Date: October 2021 Page 8 of 12

Department of Health (2013) HBN 00-09 Infection Control in the Built Environment Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/17070 5/HBN_00-09_infection_control.pdf Review Date: October 2021 Page 9 of 12

APPENDIX 1: COMMUNICATION PLAN COMMUNICATION PLAN The following action plan will be enacted once the document has gone live. Staff groups that need to have knowledge of the strategy/policy Staff who have duties and responsibilities within this policy The key changes if a revised policy/strategy The key objectives How new staff will be made aware of the policy and manager action No significant changes other than formatting to match Trust policy template and harmonisation with community services To ensure there is a framework for estates and facilities managers and planners to work in collaborative partnership with the IPC team to deliver facilities in which IPC needs have been planned for, anticipated and met Cascade by email to relevant staff Specific Issues to be raised with staff Training available to staff Any other requirements Issues following Equality Impact Assessment (if any) No negative impacts Location of hard / electronic copy of the document etc. Hard copy of policy in Site Management office and Infection Control Team Office. Electronic version on Hub. Review Date: October 2021 Page 10 of 12

APPENDIX 2: EQUALITY IMPACT ASSESSMENT TOOL Name of document Division/Directorate and service area Name, job title and contact details of person completing the assessment Infection Control in the Built Environment Policy Infection Prevention & Control Judy Potter Lead Nurse/Director of Infection Prevention & Control Ext: 2355 Date completed: 29 th March 2017 The purpose of this tool is to: identify the equality issues related to a policy, procedure or strategy summarise the work done during the development of the document to reduce negative impacts or to maximise benefit highlight unresolved issues with the policy/procedure/strategy which cannot be removed but which will be monitored, and set out how this will be done. 1. What is the main purpose of this document? To ensure infection control issues are factored in in design and management of buildings 2. Who does it mainly affect? (Please insert an x as appropriate:) Carers Staff Patients Other (please specify) 3. Who might the policy have a differential effect on, considering the protected characteristics below? (By differential we mean, for example that a policy may have a noticeably more positive or negative impact on a particular group e.g. it may be more beneficial for women than for men) Protected characteristic Relevant Not relevant Age Disability Sex - including: Transgender, and Pregnancy / Maternity Race Religion / belief Sexual orientation including: Marriage / Civil Partnership Review Date: October 2021 Page 11 of 12

4. Apart from those with protected characteristics, which other groups in society might this document be particularly relevant to (e.g. those affected by homelessness, bariatric patients, end of life patients, those with carers etc.)? 5. Do you think the document meets our human rights obligations? Feel free to expand on any human rights considerations in question 6 below. A quick guide to human rights: Fairness how have you made sure it treat everyone justly? Respect how have you made sure it respects everyone as a person? Equality how does it give everyone an equal chance to get whatever it is offering? Dignity have you made sure it treats everyone with dignity? Autonomy Does it enable people to make decisions for themselves? 6. Looking back at questions 3, 4 and 5, can you summarise what has been done during the production of this document and your consultation process to support our equality / human rights / inclusion commitments? 7. If you have noted any missed opportunities, or perhaps noted that there remains some concern about a potentially negative impact please note this below and how this will be monitored/addressed. Protected characteristic : Issue: How is this going to be monitored/ addressed in the future: Group that will be responsible for ensuring this carried out: Review Date: October 2021 Page 12 of 12